" class="no-js "lang="en-US"> Matt Hayes - Medtech Alert
Sunday, January 19, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Matt Hayes

Matt Hayes

About Matt Hayes

Chief Technology Officer and Founder at Evonetix Ltd. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology.

Specialties: Medical device development
Analogue ASIC design
Opto-electronics

Related Story

News

 Evonetix Commences Early Access Program for DNA Synthesised by Thermal Control on Its Semiconductor Chip | Pharmtech Focus

Evonetix Commences Early Access Program for DNA Synthesised by Thermal Control on Its Semiconductor Chip

August 17 2022

EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced […]

News

 Evonetix Granted Patent for DNA Data Storage and Retrieval Method | Pharmtech Focus

Evonetix Granted Patent for DNA Data Storage and Retrieval Method

September 22 2021

EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and […]